Market overview
The global cardiovascular enterprise viewer market is worth USD 486 mn in 2026 and is forecast to reach USD 1.0 bn by 2036, growing at a 7.5% CAGR. United States is the largest country market and Echocardiography is the largest by modality segment.
| Scope | Enterprise software for viewing and reporting cardiovascular images and data: echo, cath lab, nuclear, CT, MRI and ECG in one viewer, sold to hospitals and heart centres as licences or subscriptions. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 450 mn |
| Value 2026 | USD 486 mn |
| Value 2036 | USD 1.0 bn |
| CAGR 2026-2036 | 7.5% |
| Volume 2026 | 6,416 installations |
| Volume 2036 | 11,971 installations |
| Average price 2026 | USD 75,750 per installation |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Cardiovascular Enterprise Viewer market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 486 mn |
| 2027 | USD 522 mn |
| 2028 | USD 562 mn |
| 2029 | USD 604 mn |
| 2030 | USD 649 mn |
| 2031 | USD 698 mn |
| 2032 | USD 750 mn |
| 2033 | USD 806 mn |
| 2034 | USD 867 mn |
| 2035 | USD 932 mn |
| 2036 | USD 1.0 bn |
Cardiovascular Enterprise Viewer market segmentation
By modality
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Echocardiography | 34.0% | 31.7% | USD 165 mn | 6.8% |
| Cath lab and haemodynamics | 26.0% | 24.3% | USD 126 mn | 6.8% |
| CT, MRI and nuclear | 22.0% | 24.7% | USD 107 mn | 8.8% |
| ECG and other | 18.0% | 19.3% | USD 87 mn | 8.3% |
By deployment
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| On-premise | 46.0% | 30.6% | USD 224 mn | 3.2% |
| Cloud | 40.0% | 55.8% | USD 194 mn | 11.1% |
| Hybrid | 14.0% | 13.6% | USD 68 mn | 7.2% |
By viewing platform
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Web based | 44.0% | 50.0% | USD 214 mn | 8.9% |
| Desktop client | 36.0% | 28.0% | USD 175 mn | 4.8% |
| Mobile | 20.0% | 22.0% | USD 97 mn | 8.5% |
By buyer
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 62.0% | 58.0% | USD 301 mn | 6.8% |
| Cardiology clinics | 22.0% | 22.0% | USD 107 mn | 7.5% |
| Imaging centers | 16.0% | 20.0% | USD 78 mn | 9.9% |
By function
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Image viewing | 40.0% | 34.0% | USD 194 mn | 5.8% |
| Reporting and measurements | 30.0% | 30.0% | USD 146 mn | 7.5% |
| AI and advanced analytics | 30.0% | 36.0% | USD 146 mn | 9.5% |
Top 25 countries for cardiovascular enterprise viewer by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 82.0% of 2026 revenue and the 25 countries below together hold 95.5%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 214 mn | 44.0% | USD 446 mn | 7.6% |
| 2 | China | USD 34 mn | 7.0% | USD 85 mn | 9.6% |
| 3 | Germany | USD 29 mn | 6.0% | USD 55 mn | 6.6% |
| 4 | Japan | USD 24 mn | 5.0% | USD 44 mn | 6.1% |
| 5 | United Kingdom | USD 24 mn | 5.0% | USD 48 mn | 7.1% |
| 6 | France | USD 19 mn | 4.0% | USD 37 mn | 6.7% |
| 7 | Italy | USD 15 mn | 3.0% | USD 26 mn | 6.0% |
| 8 | Canada | USD 15 mn | 3.0% | USD 29 mn | 7.1% |
| 9 | Australia | USD 12 mn | 2.5% | USD 25 mn | 7.5% |
| 10 | Spain | USD 12 mn | 2.5% | USD 23 mn | 6.6% |
| 11 | India | USD 12 mn | 2.4% | USD 26 mn | 8.1% |
| 12 | Brazil | USD 9.1 mn | 1.9% | USD 20 mn | 8.2% |
| 13 | South Korea | USD 7.0 mn | 1.4% | USD 15 mn | 8.2% |
| 14 | Netherlands | USD 5.9 mn | 1.2% | USD 11 mn | 6.9% |
| 15 | Sweden | USD 5.8 mn | 1.2% | USD 11 mn | 7.0% |
| 16 | Switzerland | USD 4.5 mn | 0.9% | USD 8.8 mn | 6.9% |
| 17 | Saudi Arabia | USD 4.1 mn | 0.8% | USD 9.0 mn | 8.1% |
| 18 | Mexico | USD 3.7 mn | 0.8% | USD 8.1 mn | 8.1% |
| 19 | Belgium | USD 3.1 mn | 0.6% | USD 6.1 mn | 7.0% |
| 20 | Poland | USD 2.6 mn | 0.5% | USD 5.7 mn | 8.1% |
| 21 | Taiwan | USD 2.2 mn | 0.5% | USD 4.8 mn | 8.2% |
| 22 | Singapore | USD 1.9 mn | 0.4% | USD 4.1 mn | 8.3% |
| 23 | United Arab Emirates | USD 1.6 mn | 0.3% | USD 3.4 mn | 8.2% |
| 24 | Austria | USD 1.3 mn | 0.3% | USD 2.5 mn | 6.7% |
| 25 | Turkey | USD 0.92 mn | 0.2% | USD 2.1 mn | 8.6% |
| Rest of world | USD 22 mn | 4.5% | USD 45 mn | 7.4% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Philips
- GE HealthCare
- Fujifilm Healthcare
- Merative
Group 2: Regional and specialist players
- Siemens Healthineers
- Agfa HealthCare
- Digisonics
- Sectra
- Intelerad
- Change Healthcare
- Visage Imaging
- Circle Cardiovascular Imaging
Group 3: Emerging and niche players
- Heart Imaging Technologies
- Medicor Imaging
- Calgary Scientific
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the cardiovascular enterprise viewer market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 7.5% is calculated from the resulting values.
The market is divided by modality, by deployment, by viewing platform, by buyer, by function. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the cardiovascular enterprise viewer market?
The global cardiovascular enterprise viewer market is estimated at USD 450 mn in 2025 and USD 486 mn in 2026.
How fast will the cardiovascular enterprise viewer market grow?
It is forecast to reach USD 1.0 bn by 2036, a compound annual growth rate of 7.5% from 2026, an increase of USD 516 mn.
Which country is the largest market for cardiovascular enterprise viewer?
United States is the largest market by revenue at USD 214 mn in 2026, 44.0% of the global total. The three largest countries together hold 57.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 9.6% a year from 2026 to 2036.
Which cardiovascular enterprise viewer segment is largest?
In the by modality split, Echocardiography is the largest segment with 34.0% of 2026 revenue.
Who are the leading cardiovascular enterprise viewer companies?
Global leaders include Philips, GE HealthCare, Fujifilm Healthcare, Merative.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Wearable Defibrillator PatchUSD 490 mn · 8.5% CAGR
- Absorbance Micro plate ReaderUSD 494 mn · 5.0% CAGR
- Waterless Bathing SolutionUSD 475 mn · 5.3% CAGR
- Osteotomy PlatesUSD 506 mn · 5.3% CAGR
- Respiratory TrainerUSD 506 mn · 5.3% CAGR
- Abdominal Closure SystemsUSD 509 mn · 6.5% CAGR
- Cell-Free DNA Testing TransplantUSD 462 mn · 10.0% CAGR
- Cosmetic Peptide ManufacturingUSD 456 mn · 8.0% CAGR
← Cardiovascular Drug Discovery Carpal Tunnel Release System →